Evidence map›Paper›PMID 40801616›Full record

ArticleCells2025

Jonas A Kengne-Ouafo, Collins M Morang'a, Nancy K Nyakoe, Daniel Dosoo, Richmond Tackie, Joe K Mutungi, Saikou Y Bah, Lucas N Amenga-Etego, Britta Urban, Gordon A Awandare and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Serological evidence of high exposure toMalariaWorld journal · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jonas A Kengne-OuafoWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.ORCID 0000-0003-3516-8498
Collins M Morang'aWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.
Nancy K NyakoeWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.
Daniel DosooWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.
Richmond TackieDepartment of Clinical Microbiology, School of Medicine and Dentistry College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, Ashanti Region, Ghana.
Joe K MutungiWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.ORCID 0000-0003-2170-7577
Saikou Y BahWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.
Lucas N Amenga-EtegoWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.
Britta UrbanDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.ORCID 0000-0002-4197-8393
Gordon A AwandareWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.
Bismarck DinkoWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.
Yaw AniwehWest African Centre for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Legon, Accra P.O. Box LG 56, Ghana.ORCID 0000-0002-8415-2727

Funding

Wellcome TrustWellcome Trust 107755/Z/15/Z: AwandareWellcome Trust 110090/Z/15/Z
6 · The paper itself

Abstract

With the increasing detection of artemisinin resistance to front-line antimalarials in Africa and notwithstanding the planned roll-out of RTS'S and R21 in Africa, the search for new vaccines with high efficacy remains an imperative. Towards this endeavour, we performed in silico screening to identify

Indexed as

Antibodies, ProtozoanAntibody FormationAntigens, ProtozoanMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsSubtilisinsErythrocytesHumansAntibodies, ProtozoanAntigens, ProtozoanProtozoan ProteinsSubtilisinsantibody responseclinical isolatesgene expressiongenetic diversitylocalizationPlasmodium falciparum

Identifiers

PMID40801616
PMCPMC12346512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.